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Adipose-derived stem cells were isolated from rats and differentiated to a Schwann cell-like phenotype
in vitro. The differentiated cells (dADSCs) underwent self-alignment in a tethered type-1 collagen gel,
followed by stabilisation to generate engineered neural tissue (EngNT-dADSC). The pro-regenerative
phenotype of dADSCs was enhanced by this process, and the columns of aligned dADSCs in the
aligned collagen matrix supported and guided neurite extension in vitro. EngNT-dADSC sheets were
rolled to form peripheral nerve repair constructs that were implanted within NeuraWrap conduits to
bridge a 15 mm gap in rat sciatic nerve. After 8 weeks regeneration was assessed using immunoﬂuo-
rescence imaging and transmission electron microscopy and compared to empty conduit and nerve graft
controls. The proportion of axons detected in the distal stump was 3.5 fold greater in constructs con-
taining EngNT-dADSC than empty tube controls. Our novel combination of technologies that can organise
autologous therapeutic cells within an artiﬁcial tissue construct provides a promising new cellular
biomaterial for peripheral nerve repair.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
Peripheral nerve injuries lead to pain and signiﬁcant disability in
many affected individuals. Each year approximately 300,000 people
of working age in Europe experience a peripheral nerve injury (PNI)
[1]; of these less than 50% regain full function after treatment [2,3].
For peripheral nerve damage that results in gaps greater than
approximately 3 cm, the current clinical gold standard treatment is
the nerve autograft. Many new therapeutic strategies for improving
nerve repair are being developed in basic, pre-clinical and clinical
trials. Results have shown that guidance conduit structures and
living cells are essential for the repair of larger nerve gaps tols & Tissue Engineering, UCL
on WC1X 8LD, UK. Tel.: þ44
r Ltd. This is an open access articleprovide trophic support and recreate the environment provided by
the nerve autograft [4e9].
Among the strategies being developed for peripheral nerve
repair, the combination of tissue engineering and stem cell tech-
nologies represents a powerful approach for generating artiﬁcial
nerve tissue that could be used in the clinical setting. We recently
developed effective technology for the production of engineered
neural tissue (EngNT), an aligned cellular biomaterial for nerve
repair [10]. The technology involved Schwann cell self-alignment
within a tethered collagen hydrogel, followed by a stabilisation
process to form robust, aligned cellular sheets. EngNT containing
aligned Schwann cells was used within a nerve repair conduit to
promote neuronal regeneration across a critical sized defect in the
rat sciatic nerve [10]. This approach differs from other tissue en-
gineering approaches because the cells and the extracellular matrix
align as a consequence of integrin-mediated cell-generated forces
acting within a constrained hydrogel environment [11]. The result
is an artiﬁcial tissue containing aligned Schwann cells distributed
evenly throughout an aligned collagen hydrogel matrix. A key
factor limiting the translation of this and other cellular tissue-under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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Schwann cells. Autologous human Schwann cells would need to be
derived from invasive nerve biopsies and sufﬁcient cell numbers for
regeneration would only become available after a lengthy expan-
sion time in vitro [12]. Schwann cell-like cells derived from stem
cells are therefore a more attractive source because they can
potentially be obtained from the patient for use in an autologous
therapy [13]. Autologous cells are generally considered to be more
readily accepted by the patient because they do not provoke an
immune reaction [7,14].
Adipose-derived stem cells (ADSCs) are an accessible source of
adult stem cells that have generated considerable interest as can-
didates for autologous cell transplantation and they are currently
being used in clinical trials for awide range of indications. Stem and
progenitor cells usually make up less than 5% of the total cell
population in adipose tissue [15], but this is 2500-fold more than
the frequency of such cells in bone marrow [16]. The abundance of
ADSCs and the ability to collect large amounts of adipose tissue via
liposuction potentially eliminates the need for cell expansion. They
are easily accessible in large quantities with little donor site
morbidity or patient discomfort. Experimental studies using rat
ADSCs have shown that these cells have the ability to differentiate
along the glial lineage, making them good potential candidates for
use as an alternative to Schwann cells in peripheral nerve repair
[17e20]. Rat ADSCs differentiated into Schwann cell-like cells
(dADSCs) express a range of Schwann cell proteins, they can pro-
mote neurite outgrowth in vitro [17e20] and enhance regeneration
in vivo [21e24]. The regenerative properties of these cells has been
attributed to their secretion of neurotrophic factors [25,26], their
ability to recruit host Schwann cells to aid the regenerative process
[27], their possible direct contribution tomyelin formation [24] and
their ability to enhance the survival of sensory and motor neurons
[28]. Importantly, recent studies indicate that human ADSCs,
stimulated by the same protocol as used in the rodent experiments,
also have a pro-regenerative phenotypewhen transplanted into the
injured peripheral nervous system [29,30].
The aforementioned studies have used a variety of different
types of conduits to deliver the dADSCs to the injury site. Cells have
been transplanted in fast resorbing ﬁbrin conduits [21,22,29],
synthetic nerve tube conduits [28,31] or naturally occurring
decellularised matrices [32]. The aim of this study was to test for
the ﬁrst time whether dADSCs can be used to generate EngNT
through cellular self-alignment followed by stabilisation within
collagen gels, avoiding the need for construction of aligned scaf-
folds and subsequent seeding of cells that is common in other tissue
engineering approaches [11]. Following characterisation of dADSC
morphology and phenotype in EngNT in vitro, EngNT-dADSC con-
structs were tested in a critical sized defect in the rat sciatic nerve
that simulates the clinical long gap injury scenario in order to
assess their ability to support neuronal growth in vivo.
2. Materials and methods
All experimental procedures involving animals were conducted in accordance
with the UK Animals (Scientiﬁc Procedures) Act (1986)/the European Communities
Council Directives (86/609/EEC) and approved by the Open University Animal Ethics
Advisory Group and the Northern Swedish Committee for Ethics in Animal
Experiments.
2.1. Isolation, culture and differentiation of adipose-derived stem cells
Fat tissue was harvested from adult rats and the ADSCs were isolated as previ-
ously described [19]. Cells were cultured in modiﬁed Eagle's medium (a-MEM;
Invitrogen, UK) containing 10% (v/v) foetal bovine serum (FBS) and 1% (v/v) peni-
cillin/streptomycin solution. The culturesweremaintained at sub-conﬂuent levels in
a 37 C incubator with 5% CO2 and passaged with trypsin/EDTA (Invitrogen, UK)
when required. The multi-potent potential of the cell cultures was assessed by
ensuring their ability to differentiate along several lineages, as described previously
[19]. To differentiate the adipose stem cells into a Schwann cell-like phenotype(dADSCs), growth medium was removed from sub-conﬂuent cultures at passage 2
and replaced with medium supplemented with 1 mM b-mercaptoethanol (Sigma-
eAldrich, UK) for 24 h. Then the cells werewashed and freshmedium supplemented
with 35 ng/ml all-trans-retinoic acid (Sigma) was added. A further 72 h later, the
cells were washed and the medium was replaced with differentiation medium
containing cell growth medium supplemented with 14 mM forskolin (Sigma), 10 ng/
ml basic ﬁbroblast growth factor (bFGF; Pepro Tech Ltd., UK), 5 ng/ml platelet-
derived growth factor (PDGF-AA; Pepro Tech Ltd., UK) and 252 ng/ml neuregulin
NRG1 (R&D Systems, UK). The cells were incubated for a minimum 2 weeks under
these conditions with fresh medium added approximately every 72 h.
2.2. Immunoﬂuorescence staining of dADSCs
Cells were seeded at a density of 10,000 cells/well in an 8-well LabTek chamber
slide and allowed to settle for 48 h before they were ﬁxed for 20 min in 4% (w/v)
paraformaldehyde at room temperature. The cells were then washed in phosphate
buffered saline (PBS) before the addition of 5% (v/v) normal goat serum (NGS) and
5% (v/v) normal horse serum (NHS) together with 0.1% Triton X-100 (v/v) in PBS for a
further 15 min at room temperature. The blocking serumwas then removed and the
primary antibodies, mouse monoclonal anti-GFAP (Millipore) and rabbit polyclonal
anti-S100B (Dako) at respective dilutions of 1:500 and 1:1000 were added and the
samples incubated overnight at 4 C. The cells were then washed in PBS, re-blocked
using NGS and NHS before addition of the secondary antibodies, Alexa 350 conju-
gated goat anti-rabbit IgG (1:50 dilution) and Alexa 488 conjugated goat anti-mouse
IgG (1:300 dilution) for 2 h at room temperature. The samples were then washed
3  15 min with PBS before repeating the blocking step with NGS and NHS. Mouse
monoclonal anti-p75NTR (Abcam, dilution 1:500) was then added and incubated
overnight at 4 C. The cells were then washed in PBS, 3  15 min, before a ﬁnal
blocking step in NGS and NHS. Finally the secondary antibody Alexa 568 conjugated
goat anti-mouse IgG (1:300 dilution) was added for 2 h at room temperature before
ﬁnal washes with PBS and addition of ProlongGold anti-fademountant. Imageswere
captured at 200 ﬁnal magniﬁcation using a Nikon Eclipse 90i microscope with a
Nikon DS-U2 digital camera. Five random images were recorded from each well and
a total of 4 wells for each preparation were imaged. dADSCs were analysed from 2
different rats and these were then used for further in vitro studies and parallel in vivo
transplantations.
2.3. Fabrication of EngNT-dADSC
EngNT was prepared according to methods described previously [10]. dADSCs
were maintained in Dulbecco's Modiﬁed Eagle's Medium (DMEM; Gibco) supple-
mented with penicillin and streptomycin (100 U/ml and 100 mg/ml, respectively;
Sigma), 10% (v/v) FBS and the growth factors used for differentiation as described
above. To prepare gels, 1 volume of 10 Minimum Essential Medium (Sigma) was
mixed with 8 volumes of type I rat tail collagen (2 mg/ml in 0.6% acetic acid; First
Link, UK) and the mixture neutralised using sodium hydroxide before addition of 1
volume of dADSCs suspension (ﬁnal density 4  106 cells per ml of gel). One ml of
this mixture was added to each mould at 4 C and integrated with tethering mesh at
opposite ends before setting at 37 C for 10 min. Tethered gels were immersed in
culture medium and incubated at 37 C in a humidiﬁed incubator with 5% CO2/95%
air for 24 h during which time the cells aligned. Aligned cellular gels were stabilised
by plastic compression: gels were separated from the tetheringmesh using a scalpel,
placed on an absorbent paper pad and immediately compressed by loading the gel
with 120 g for 1 min during which time ﬂuid was absorbed by the paper pad un-
derneath [33]. The resulting sheets of EngNT were either transferred directly to 24-
well plates for in vitro experiments, or rolled to form rods (approximately 200 mm
diameter 15 mm length) and maintained in culture medium for up to 24 h prior to
in vivo experiments.
2.4. RT-PCR of cultured dADSCs and EngNT-dADSC
Total RNAwas isolated from the samples using an RNeasy™ kit (Qiagen) and one
step RT-PCR (Qiagen) was performed using 1 ng of RNA per reaction mix. The
samples were loaded into a thermocycler (Biometra, Germany) whichwas usedwith
the following parameters: a reverse transcription (RT) step (50 C, 30 min) and a
nucleic acid denaturation/RT inactivation step (95 C, 15 min) followed by 28e34
cycles of denaturation (95 C, 30 sec), annealing (30 sec) and primer extension
(72 C, 1 min) followed by a final extension incubation (72 C, 5 min). Forward and
reverse primer (all 50/ 30) pairs for a variety of glial cell markers and neurotrophic
factors were manufactured by SigmaAldrich and are listed in Table 1 together with
their annealing temperatures. The reaction product ampliconswere electrophoresed
at 50 V for 90 min through a 1.5% (w/v) agarose gel and their size was estimated
using Hyperladder IV (Bioline, UK). Samples were visualised under ultraviolet (UV)
illumination following GelRed™ nucleic acid stain (Bio Nuclear, Sweden) incorpo-
ration into the agarose.
2.5. Assessment of EngNT-dADSC in co-culture with neurons
Dissociated dorsal root ganglion (DRG) neurons were prepared from adult
(200e300 g) Sprague Dawley rats. DRGs were incubated in collagenase (0.125%;
Sigma) for 1.5 h at 37 C then dissociated by trituration andwashed twicewith 20ml
Table 1
Primer sequences for RT-PCR and annealing temperatures used (C).
Gene Forward primer (50 / 30) Reverse primer (50 / 30) C
S100B GTTGCCCTCATTGATGTCTTC AGACGAAGGCCATAAACTCCT 57.9
GFAP GCTGAACTGAACCAGCTTCGA CTTGGCCACATCCATCTCCAC 57.3
P75 GAGCCGTGCAAGCCGTGCAAC CTCAGGCTCCTGGGTGCTGGG 64
P0 GGTGGTGCTGTTGCTGCTG TTCGTGCTTCGGCTGTGGTC 68.0
NGF AAGGATCCTGGACCCAAGCTCACCTCA GAGTGACGTGGATGAGCGCTTGCTCCT 67.0
BDNF ATGGGACTCTGGAGAGCGTGAA CGCCAGCCAATTCTCTTTTTGC 65.3
GDNF TCACCAGATAAACAAGCGGC TACATCCACACCGTTTAGCG 61.0
VEGF-A TGCACCCACGACAGAAGGGGA TCACCGCCTTGGCTTGTCACA 60.0
18S TCAACTTTCGATGGTAGTCGC CCTCCAATGGATCCTCGTTAA 62.1
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(0.01 mM) to deplete glia. The resulting cultures with a purity of >99% neurons were
seeded onto the surface of EngNT-dADSC sheets, allowed to settle for 30 min, then
constructs were immersed in culture medium at 37 C in a humidiﬁed incubator
with 5% CO2/95% air. After 3 days the co-cultures were washed brieﬂy in PBS and
ﬁxed in 4% (w/v) paraformaldehyde at 4 C for 24 h, then immunoﬂuorescence
staining was carried out as described previously for collagen gels [34,35] to detect
bIII-tubulin positive neurons and S100B positive dADSCs.
Confocal microscopy (Leica SP5) was used to assess the neurite alignment in the
EngNT-dADSC-neuron co-cultures. Six equivalent ﬁelds were analysed per gel using
a standardised sampling protocol. Images were captured using a 40 oil immersion
lens, z-stacks were 20 mm with a step size of 1 mm. Image analysis was conducted
using Volocity™ software (Perkin Elmer, Waltham, MA) running automated 3D
image analysis protocols to measure the angle of dADSC alignment and of neurite
alignment compared to the long axis of the construct.
2.6. Surgical repair of rat sciatic nerve
Sprague Dawley (250e500 g) rats were deeply anesthetised by inhalation of
isoﬂurane, the left sciatic nerve of each animal was exposed at mid-thigh level,Fig. 1. Characterisation of transplanted cells. Adipose tissue derived stem cells were treat
Immunostaining for S100B, GFAP, and P75 showed the majority of the cells expressed all 3 S
positive (arrows). Scale bar ¼ 25 mm.transected and then either a repair conduit or a nerve graft was positioned be-
tween the stumps to produce an inter-stump distance of 15 mm. Conduits or grafts
were retained in place using three 10/0 epineurial sutures at each stump, then
wounds were closed in layers and animals were allowed to recover for 8 weeks.
Neuronal regeneration was assessed across a 15 mm inter-stump distance and
included three groups (7 rats in each): (A) empty NeuraWrap™ conduit, (B) two
EngNT-dADSC rods in a NeuraWrap™ sheath (18 mm long) or (C) a 15 mm nerve
graft taken from a littermate culled using CO2 asphyxiation. Animals were culled
following the recovery period using CO2 asphyxiation and repaired nerves were
excised under a dissecting microscope. The middle of the repair device was
removed and prepared for transmission electron microscopy (TEM), and transverse
cryostat sections (10 mm thick) were prepared from the proximal and distal parts of
the device and the nerve stumps. The transverse sections that were used for
analysis were from positions 1 mm into the proximal and distal stumps, or 1 mm
into the proximal and distal parts of the repair site, measured from the end of the
nerve stump in each case.
Sections were blocked using 5% horse serum for 20 min then immunostained
using mouse monoclonal anti-200 kDa neuroﬁlament to detect axons (1:1000,
Covance, Princeton, NJ) and visualised with DyLight 549 horse anti-mouse
immunoglobulin secondary antibody (1:200, Vector Laboratories, Burlingame,ed with a mixture of glial growth factors as described in the Materials and Methods.
chwann cell markers, the remaining cells were predominantly S100B and GFAP double
Fig. 2. Characterisation and alignment of Schwann cell-like cells (dADSC) within engineered neural tissue (EngNT). (A) RT-PCR showing the expression of Schwann cell molecules
and growth factors expressed by dADSCs cultured on tissue culture plastic substrate (TCPS) and within EngNT. 18S was used as a house-keeping control gene. (B) Confocal mi-
crographs show highly aligned and elongated cells labelled with S100B. Z-distance 20 mm, step size 1 mm, scale bars are 100 mm. (C) Image analyses indicated that the cells were
predominantly aligned with the long axis of the material. Data are mean frequency of angle deviation (in 10 bins) ± SEM from 3 ﬁelds in each construct, n ¼ 3 independent gels.
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was incubated at room temperature for 45 min. Sections were mounted using
VECTASHIELD mounting medium (Vector Laboratories, Peterborough, UK) and
ﬂuorescence microscopy (Olympus BX61) was used to quantify axonal growth by
counting all of the neuroﬁlament positive axons present in each transverse
section.2.7. TEM
After excision and dissection of the middle of the repair constructs, samples
were ﬁxed in 4% (w/v) paraformaldehyde in PBS for 24 h at 4 C. These were
post-ﬁxed in 1% (w/v) osmium tetroxide in PBS, dehydrated through a graded
series of acetone, ﬂat-embedded in Epon epoxy resin and polymerized at 60 C
for 48 h. Semi-thin sections of 1 mm were cut using a glass knife on a UCT ultra
microtome (Leica, UK), dried onto poly-L-lysine coated microscope slides and
stained with 1% (w/v) toluidine blue with added 5% (w/v) sodium borate. Ul-
trathin sections of 70 nm were cut with a diamond knife (Diatome, UK) and
collected on copper slot grids with Pioloform/carbon support ﬁlms. Sections
were counter-stained with aqueous uranyl acetate and Reynolds' lead citrate
before examination in a JEM 1400 TEM (JEOL, UK). Ultrathin sections were
imaged at a column magniﬁcation of 2000 from the areas of greatest regen-
eration density as identiﬁed from the respective stained semi-thin sections.
These images were coded for subsequent analyses, and Image J software was
used to measure axon and ﬁbre diameter, myelin thickness and G-ratio were
calculated where appropriate.2.8. Statistical analysis
Normality of data was tested using a KolmogoroveSmirnov normality test prior
to using either one-way or repeated measures ANOVA where appropriate. Where
ANOVA showed a statistically signiﬁcant result (P < 0.05), a Tukey's post-test was
performed to compare all pairs of groups and the P values from the post-test are
indicated on the ﬁgures.3. Results
3.1. Characterisation and testing of EngNT-dADSC in vitro
Rat adipose-derived stem cells were differentiated to a Schwann
cell-like phenotype (dADSCs) as previously described [19]. After
two weeks in vitro differentiation, 81.88 ± 4.69% of the dADSCs
showed positive immunoreactivity for the Schwann cell markers
S100B, GFAP and P75 (Fig. 1). Preliminary studies determined the
optimum cell-seeding density for dADSCs to align within tethered
collagen gels within 24 h (4  106 cells/ml) and conﬁrmed that the
cells survived the stabilisation process (cell viability was
99.5 ± 0.86% (mean ± SEM, n ¼ 4) assessed using propidium iodide
exclusion). The pattern of gene expression for key markers of the
Schwann cell lineage was compared in dADSCs growing on tissue
culture polystyrene and in EngNT (Fig. 2A). RT-PCR analysis showed
that cells growing in the EngNT also expressed a wide range of
neurotrophic factors (Fig. 2A). Confocal microscopy showed that
the EngNT contained elongated dADSCs exhibiting a bipolar
morphology (Fig. 2B) and orientated parallel to the long axis of the
material, with over 65% of the cells showing a deviation of less than
30 from the long axis (Fig. 2C).
To determine the ability of the EngNT-dADSCs to support and
guide neuronal growth, primary rat DRG neurons were seeded onto
the surface of the aligned cellular sheets and maintained in culture
for 3 days. Long neurites were detected growing in close contact
with the columns of aligned dADSCs in thematerial (Fig. 3A). The 3-
dimensional orientation of the neurites corresponded closely to the
Fig. 3. EngNT-ADSC supports and guides neuronal growth in vitro. (A) Confocal micrographs show the dADSC (red) supporting aligned neurite growth (green) after 3 days in co-
culture (z-dimension 20 mm, step size 1 mm, scale bars are 100 mm). (B) Three-dimensional image analysis was used to quantify the neuronal growth from 6 ﬁelds in each construct
(the total length of extended neurites in the sampled area was 9447 ± 1710 mm, mean ± SEM, and the total area sampled per construct was 0.736 mm2). The angle of neurite growth
was compared to the long axis of the material and revealed that the neurite growth was mainly parallel to the long axis of the material, which also corresponds to the direction of
dADSC alignment. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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deviation of less than 30 from the long axis of the gel (Fig. 3B).3.2. EngNT-dADSC supports neuronal regeneration in vivo
EngNT-dADSC sheets were rolled to form rods, then two rods
were ensheathed within a NeuraWrap™ conduit to form an
implantable device. EngNT-dADSC conduits were tested in a 15 mm
gap in the rat sciatic nerve over an 8 week recovery period and
compared to empty NeuraWrap or nerve graft controls. Toluidine
blue stained semi-thin sections from the middle of the repairs
showed that regenerated neural tissue was present throughout the
nerve graft and EngNT-dADSC samples with sparse smaller patches
present in the empty tube controls (Fig. 4A). The areas of highest
density were selected for TEM (Fig. 4B) and the diameter of nerve
ﬁbres and the extent of myelination assessed (Supplementary
Fig. 1). Myelin thickness was signiﬁcantly lower in the empty
tube controls compared to the nerve graft group, whereas there
was no signiﬁcant difference in myelin thickness between the
EngNT-dADSC group and the nerve graft group. There were no
signiﬁcant differences in axon diameter, ﬁbre diameter or G-ratio
between the three experimental groups.
Detailed analyses were conducted using immunohistochemistry
in multiple locations within the repaired nerve tissue (proximal
stump, PS; proximal part of the device, PD; distal part of the device,
DD; distal stump, DS) to investigate neuronal regeneration (Fig. 5Aand B). All three groups showed similar numbers of axons in the
proximal stumps, with half the number of axons present in the
proximal part of the empty tube controls compared to thenerve graft
group (Fig. 6A). In the distal part of the repairs and the distal stumps
there was minimal regeneration through the empty tube controls,
conﬁrming that this rat modelmimics the poor regeneration seen in
critical size ‘long-gap’ repairs inhumans. TheEngNT-dADSCconduits
supported 3.5-fold more regenerating axons than the empty tube
controls in both theDD andDS, although this was signiﬁcantly fewer
than in the nerve graft controls (Fig. 6A). To normalise for the dif-
ferences ingrowthofneurons into thedifferent repair constructs and
facilitate comparisons, the number of axons in the distal regionswas
expressed as a percentage of the number of axons detected in the
proximal part of the repair in each case (Fig. 6B).4. Discussion
Here we report the formation of EngNT using dADSCs, the
characterisation of dADSC phenotype within EngNT, and the ability
of EngNT-dADSC to support and guide neurite regeneration in vitro.
When implanted within a critical-sized defect in the rat sciatic
nerve, EngNT-dADSC supported robust neural regeneration across
the gap and into the distal stump. The combination of dADSCs with
the EngNT assembly technique provides a promising method for
building replacement peripheral nerve tissue using autologous
cells.
Fig. 4. EngNT-dADSC supports neuronal regeneration in a long gap rat sciatic nerve injury model. (A) Representative semi-thin sections stained with toluidine blue were taken from
the mid-point of the conduits or grafts 8 weeks following nerve repair (20 magniﬁcation). (B) The areas with the highest density were sampled and imaged with TEM
(M ¼myelinated axon, S ¼ Schwann cell nucleus, scale bar 2 mm). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this
article.)
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conditions and after they had been transplanted and aligned in the
collagen gels. Consistent with previous studies the dADSCs
expressed a range of Schwann cell markers and neurotrophic fac-
tors [19,28]. Importantly the expression of these markers was
maintained in the gels. The differentiation process used to generate
the dADSCs has been shown to enhance the ability of the cells to
evoke in vitro neurite outgrowth [17,19] and this has been attrib-
uted to elevated levels of NGF and BDNF [18]. Stimulation of human
cells also increases the expression of NGF, BDNF and GDNF [29,30].
Furthermore, the cells cultured in the collagen gels showed
enhanced levels of growth factor mRNAs compared to those
cultured on tissue culture plastic. This might be a consequence of
placing the cells in 3D or of speciﬁc cell-ECM interactions within
the gels. For example, previously it was shown that the ECM mol-
ecules ﬁbronectin and laminin can activate the dADSC to a more
neurotrophic phenotype, although no changes in speciﬁc growth
factor expression levels could be detected [36]. Interestingly there
was an indication that the expression of GFAP may have decreased
when dADSCs were incorporated in the EngNT, which is consistent
with our previous data comparing astrocyte GFAP expression in
monolayer and 3D cell culture [34].
Morphologically the dADSCs adopted an aligned elongated
shape in the tethered collagen gels that persisted in the EngNT and
was reminiscent of the Schwann cells in the Bands of Büngner [37].The effectiveness of EngNT-dADSC to support and guide regener-
ation of DRG neurons was demonstrated using a co-culture model
in which regenerating neurites appeared to grow along the chains
of aligned dADSCs. This is in line with our previous work using
other cells in EngNT [10,38] and previous reports from others that
used cell level topography and Schwann cell-neuron contact to
direct neuronal growth [39e41]. Three-dimensional quantiﬁcation
of the angle of neurite orientation conﬁrmed that the EngNT-
dADSC guided regeneration along the long axis of the cellular
material. This type of anisotropy is a critical feature in the design of
nerve repair materials [5], where the support of robust neuronal
regeneration must also be directed efﬁciently across the gap to
facilitate rapid recovery.
Given the positive results obtained using EngNT-dADSC in vitro
we proceeded to investigate the effects in vivo. Rat dADSCs have
previously been shown to boost the rate of early axon regeneration
and enhance sensory neuron survival in a rat sciatic nerve injury
model [22,28]. Stimulated human adipose stem cells also enhance
the in vivo expression levels of regeneration associated genes [29].
The mechanism of the action of the stem cells has not been
deﬁnitively elucidated but some studies suggest that they work by
either releasing growth factors themselves [42] or by modulating
the endogenous Schwann cells [27]. Magnetic resonance imaging
(MRI) has also conﬁrmed the effects of ADSCs on the early histo-
logical measurements of axon regeneration. Tremp et al. were able
Fig. 5. EngNT-dADSC supports regeneration through a 15 mm repair device and into the distal stump. (A) Transverse sections were taken at four different positions within the repair
site; the proximal stump (PS), proximal device (PD), distal device (DD) and distal stump (DS). (B) Micrographs show neuroﬁlament antibody staining used to detect regenerating
axons in the graft, empty tube and EngNT-dADSC (scale bars 100 mm). Insets show lower magniﬁcation views of the cross sections (scale bars 200 mm).
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cantly longer in rats treated with dADSCs compared with an empty
tube control [43].
The majority of the studies investigating the effects of dADSCs
on nerve regeneration have utilised the 10 mm rat sciatic nerve
injury model. There is little consensus about the most appropriate
pre-clinical model to use for testing peripheral nerve repair devices[44], so in this study we chose a relatively long gap (15 mm) and
short time point (8 weeks) in the rat sciatic nerve which we know
from our previous studies is a critical sized defect that shows poor
regeneration when empty tubes are used, as reﬂects the long-gap
situation in humans [10]. There are numerous possible methods
for delivering EngNT to the site of nerve injury and further opti-
misation of the assembly and organisation of EngNT sheets into
Fig. 6. Quantiﬁcation of regeneration through the grafts and repair devices. (A) The ability of the repairs to support regeneration through the device and into the distal stump was
assessed by counting the number of neuroﬁlament positive axons (y axis) at the four different positions through the repairs, proximal stump (PS), proximal device (PD), distal device
(DD) and distal stump (DS). Data are means ± SEM showing the number of axons in each repair at the different positions. (B) The ability of each repair to support neuronal growth
was assessed by comparing the number of axons detected at the proximal part of the conduit to those detected at the distal end and in the distal stump. Data are means ± SEM.
*P < 0.05, **P < 0.01, ***P < 0.001, repeated measures ANOVA with Tukey's post-test.
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the subject of future investigations. For the purposes of this work,
EngNT-dADSC sheets were rolled to form rods of 15 mm
length  200 mm diameter and two of themwere implanted within
each NeuraWrap sheath as described previously [10]. This approach
of rolling the EngNT sheets to form rods enabled them to be
handled easily so they could be positioned between the nerve
stumps, providing a continuous column of aligned dADSCs across
the repair site.
Analysis of the mid-point of the repair site after 8 weeks
revealed that there was considerably more regenerated neural
tissue present in the EngNT-dADSC repairs compared to the emptytube control group. Ultrastructural examination showed that the
pattern of myelinated and unmyelinated nerve ﬁbres present in the
EngNT-dADSC repairs resembled that in the nerve graft controls,
whereas regeneration in the empty tubes was sparse. There were
no signiﬁcant differences in nerve ﬁbre diameter, axon diameter
and G ratio between any of the groups, although myelin thickness
was signiﬁcantly reduced in the empty tube controls. As reported
previously with EngNT-Schwann cells in the same model, this in-
dicates that the quality of regeneration is similar in all groups and
the main difference between them is the overall amount of
regeneration [10]. From these experiments it is not possible to
determine whether the dADSCs themselves are responsible for
M. Georgiou et al. / Biomaterials 37 (2015) 242e251250myelinating the regenerating axons or if they enhance the myeli-
nation by the endogenous Schwann cells. However, in vitro studies
have shown that dADSCs can formmyelinwhereas undifferentiated
ADSC do not [45]. There is also some immunohistochemical evi-
dence that transplanted dADSC actively contribute to the formation
of myelin sheaths in a chronically denervated rat common peroneal
nerve model [24].
To investigate the ability of EngNT-dADSC to support neuronal
growth from the proximal to the distal stump, analyses were car-
ried out to assess the number of regenerating neurites at different
points across the repair site. Approximately 50% of the axons re-
generated across the 15 mm inter-stump gap from the proximal to
distal part of the device, and approximately 44% of the axons in the
proximal part of the device traversed the gap and entered the distal
stump. In contrast, only 12% of the axons in the proximal end re-
generated through the empty conduit and into the distal stump.
Previous studies have shown that ADSCs can support regeneration
across short gaps. dADSCs transplanted in ﬁbrin nerve conduits to
treat a 10 mm sciatic nerve defect were shown to enhance the
number of regenerating motor neurons, improve electrophysio-
logical outcomes and increase distal axon myelination [21]. In
another study, trans-differentiated ADSCs were combined with
decellularised artery grafts to treat a rat facial nerve lesion [46]. The
transplanted cells maintained their Schwann cell-like phenotype
and myelin forming capabilities and long term morphological and
functional evaluations showed that these cells were as effective as
Schwann cells [46]. Manipulation of ADSCs by alternative differ-
entiation protocols has also been shown to generate cells with
enhanced regenerative capabilities for peripheral nerve repair
[23,32,47]. As far as we are aware only one other study has utilised
ADSCs in the 15 mm rat sciatic nerve gap model [48]. In that study,
Schwann cell-like ADSCs were used to supplement acellular nerve
grafts and the combined grafts showed positive effects on nerve
regeneration and some enhancements in functional recovery
compared with the acellular grafts [48].
5. Conclusions
Our results show that the EngNT-dADSC can be used to form an
effective peripheral nerve repair device to bridge a critical sized
nerve gap. Adipose-derived stem cells are an ideal candidate for a
neural cell therapy because they are easily accessible from the
patient for use in an autologous cell therapy, eliminating the risk of
rejection from the patient, and they can be expanded in a controlled
and reproducible manner. The dADSCs show phenotypic charac-
teristics of Schwann cells and secrete a plethora of growth factors
important for peripheral nerve regeneration. Importantly, the
regenerative phenotype of dADSCs is enhanced in EngNT, both in
terms of expression of neurotrophic and angiogenic factors and in
terms of morphology and organisation. This is therefore a poten-
tially powerful approach for delivering these cells within a pe-
ripheral nerve repair conduit. Enhancing the pro-regenerative
phenotype of dADSCs while simultaneously organising the cells
into aligned columns within a stable aligned collagen matrix pro-
vides a convenient means to assemble an artiﬁcial repair tissue.
Furthermore, delivering dADSCs via stable EngNT constructs pro-
vides a way to distribute and organise the therapeutic cells within
the nerve repair environment, offering a level of control that is not
possible when cells are delivered in suspension or within dis-
organised unstable hydrogels. Future work will focus on optimi-
sation of EngNT-dADSC to enhance further the pro-regenerative
phenotype of the cells and determine the most effective way to
organise the material to promote regeneration that leads to im-
provements in recovery of function in vivo. It will also be important
to explore the use of human ADSCs in EngNT in order to developthis potentially beneﬁcial combination of technologies towards the
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